ATE501278T1 - Verfahren zur verwendung von il-21 - Google Patents
Verfahren zur verwendung von il-21Info
- Publication number
- ATE501278T1 ATE501278T1 AT06792239T AT06792239T ATE501278T1 AT E501278 T1 ATE501278 T1 AT E501278T1 AT 06792239 T AT06792239 T AT 06792239T AT 06792239 T AT06792239 T AT 06792239T AT E501278 T1 ATE501278 T1 AT E501278T1
- Authority
- AT
- Austria
- Prior art keywords
- individual
- predicting
- therapy
- patient
- detecting
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 2
- 108010017411 Interleukin-21 Receptors Proteins 0.000 abstract 1
- 239000012472 biological sample Substances 0.000 abstract 1
- 238000000338 in vitro Methods 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
- 230000004797 therapeutic response Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/172—Haplotypes
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Engineering & Computer Science (AREA)
- Analytical Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- General Engineering & Computer Science (AREA)
- Pathology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Immunology (AREA)
- Biotechnology (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US71938805P | 2005-09-22 | 2005-09-22 | |
| PCT/EP2006/009239 WO2007039147A1 (en) | 2005-09-22 | 2006-09-22 | Methods of using il-21 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE501278T1 true ATE501278T1 (de) | 2011-03-15 |
Family
ID=37649383
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT06792239T ATE501278T1 (de) | 2005-09-22 | 2006-09-22 | Verfahren zur verwendung von il-21 |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US20070111239A1 (de) |
| EP (2) | EP2311995A1 (de) |
| JP (1) | JP5208746B2 (de) |
| AT (1) | ATE501278T1 (de) |
| AU (1) | AU2006299141B2 (de) |
| CA (1) | CA2620338A1 (de) |
| DE (1) | DE602006020601D1 (de) |
| ES (1) | ES2360728T3 (de) |
| IL (1) | IL189597A (de) |
| WO (1) | WO2007039147A1 (de) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8315816B2 (en) * | 2005-02-16 | 2012-11-20 | Genetic Technologies Limited | Methods of genetic analysis involving the amplification of complementary duplicons |
| EP2311995A1 (de) * | 2005-09-22 | 2011-04-20 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Verfahren zur Verwendung IL-21 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0636186B1 (de) | 1992-04-03 | 1998-11-25 | The Perkin-Elmer Corporation | Proben zusammensetzung und verfahren |
| US5605798A (en) | 1993-01-07 | 1997-02-25 | Sequenom, Inc. | DNA diagnostic based on mass spectrometry |
| DE69433811T2 (de) | 1993-01-07 | 2005-06-23 | Sequenom, Inc., San Diego | Dns - sequenzierung durch massenspektronomie |
| US5571676A (en) | 1995-06-07 | 1996-11-05 | Ig Laboratories, Inc. | Method for mismatch-directed in vitro DNA sequencing |
| US5773346A (en) | 1995-12-06 | 1998-06-30 | Micron Technology, Inc. | Semiconductor processing method of forming a buried contact |
| US6576744B1 (en) | 1998-09-23 | 2003-06-10 | Zymogenetics, Inc. | Cytokine receptor zalpha11 |
| US6803451B2 (en) | 1998-09-23 | 2004-10-12 | Zymogenetics, Inc. | Cytokine receptor zalpha11 polypeptides |
| US6307024B1 (en) | 1999-03-09 | 2001-10-23 | Zymogenetics, Inc. | Cytokine zalpha11 Ligand |
| AU2003251633A1 (en) * | 2002-07-01 | 2004-01-19 | The Government Of The United States Of America As Represented By The Secretary Of The Department Of | Il-21 as a regulator of immunoglobin production |
| JP2006525223A (ja) * | 2002-10-11 | 2006-11-09 | ノボ・ノルデイスク・エー／エス | Ｉｌ２１の使用によるアレルギー症状の治療 |
| US20060177421A1 (en) * | 2002-10-11 | 2006-08-10 | Novo Nordisk A/S | Treatment of allergic conditions by use of il 21 |
| EP1573006B1 (de) | 2002-12-13 | 2009-11-11 | ZymoGenetics, Inc. | Il-21-produktion in prokaryontischen wirten |
| EP2311995A1 (de) * | 2005-09-22 | 2011-04-20 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Verfahren zur Verwendung IL-21 |
-
2006
- 2006-09-22 EP EP10185146A patent/EP2311995A1/de not_active Withdrawn
- 2006-09-22 US US11/534,332 patent/US20070111239A1/en not_active Abandoned
- 2006-09-22 AT AT06792239T patent/ATE501278T1/de active
- 2006-09-22 DE DE602006020601T patent/DE602006020601D1/de active Active
- 2006-09-22 EP EP06792239A patent/EP1937838B1/de not_active Not-in-force
- 2006-09-22 AU AU2006299141A patent/AU2006299141B2/en not_active Ceased
- 2006-09-22 JP JP2008531618A patent/JP5208746B2/ja not_active Expired - Fee Related
- 2006-09-22 WO PCT/EP2006/009239 patent/WO2007039147A1/en not_active Ceased
- 2006-09-22 ES ES06792239T patent/ES2360728T3/es active Active
- 2006-09-22 CA CA002620338A patent/CA2620338A1/en not_active Abandoned
-
2008
- 2008-02-18 IL IL189597A patent/IL189597A/en not_active IP Right Cessation
-
2010
- 2010-06-17 US US12/817,857 patent/US20100291029A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| IL189597A0 (en) | 2008-08-07 |
| EP1937838A1 (de) | 2008-07-02 |
| WO2007039147A1 (en) | 2007-04-12 |
| EP2311995A1 (de) | 2011-04-20 |
| US20100291029A1 (en) | 2010-11-18 |
| AU2006299141A1 (en) | 2007-04-12 |
| CA2620338A1 (en) | 2007-04-12 |
| EP1937838B1 (de) | 2011-03-09 |
| IL189597A (en) | 2012-06-28 |
| DE602006020601D1 (de) | 2011-04-21 |
| ES2360728T3 (es) | 2011-06-08 |
| JP5208746B2 (ja) | 2013-06-12 |
| AU2006299141B2 (en) | 2011-11-24 |
| JP2009508506A (ja) | 2009-03-05 |
| US20070111239A1 (en) | 2007-05-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Wang et al. | Direct observation of calcium-independent intercellular ATP signaling in astrocytes | |
| BR0316969A (pt) | Tratamento de mal de huntington com epa | |
| ATE406575T1 (de) | Verfahren zur erkennung von medikamentenempfindlichkeit in patienten mit entzündungskrankheiten | |
| EP2239262A3 (de) | Annellierte heterocyclische Verbindungen als Kinase-Modulatoren | |
| ATE390925T1 (de) | Verwendung von substituierten chinolin-derivaten zur behandlung von arzneimittelresistenten mycobakteriellen erkrankungen | |
| DE602005025106D1 (de) | Methoden zur medikamentenaufspürung auf der basis von in vitro differenzierten zellen | |
| EP1913149A4 (de) | Gezielte integration und expression exogener nukleinsäuresequenzen | |
| CY1111612T1 (el) | Μεθοδος για προβλεψη της αποκρισης σε μια θεραπευτικη αγωγη με εναν αναστολεαδιmερισmου του her | |
| ATE475432T1 (de) | Arzneimittel für herzversagen | |
| BR0111125A (pt) | Moléculas de ácido nucléico de nrg-2, polipeptìdeos, e métodos diagnóstico e terapêuticos | |
| EP1807505A4 (de) | Verfahren zur verbesserung der proliferation und/oder des überlebens mesenchymaler vorläuferzellen (mpc-zellen) | |
| EA200802213A1 (ru) | Способы лечения заболеваний крови | |
| DE60323300D1 (de) | Apparat zur Früherkennung von ischämischen Herzerkrankungen | |
| CY2015025I2 (el) | Μεθοδοι για την αντιμετωπιση της νοσου παρκινσον | |
| ATE375518T1 (de) | Diagnoseverfahren für erkrankungen unter verwendung von copeptin | |
| DE60028830D1 (de) | Anti-april antikörper und hybridomazellen | |
| WO2008088854A3 (en) | Genetic markers for predicting responsiveness to combination therapy | |
| EP2246422A4 (de) | Polynukleotid oder analogon davon und verfahren zur genexpressionsregulierung mit dem polynukleotid oder dem analogon davon | |
| NO20024240L (no) | Nye arylfruktose-1,6-bisfosfataseinhibitorer | |
| EP1796625A4 (de) | Neue fenofibrat-formulierungen und relevante behandlungsmethoden | |
| EP1781800A4 (de) | Verfahren zur plasmid-dna-fermentation | |
| Shi et al. | Influence of static forces on the expression of selected parameters of inflammation in periodontal ligament cells and alveolar bone cells in a co-culture in vitro model | |
| EP1769748A4 (de) | Instrument zur messung der blutgefäss-endothel-reaktion und verfahren zur steuerung des instruments zur messung der blutgefäss-endothel-reaktion | |
| ATE508201T1 (de) | Verfahren zur generierung eines gentechnisch veränderten organismus für das wirksubstanzscreening | |
| ATE475315T1 (de) | Mittel zur biologischen bekämpfung pilzlicher pflanzenkrankheiten |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1937838 Country of ref document: EP |